Pan-cancer studies have also shown that the ability of GPNMB to activate the PI3K-AKT pathway is positively correlated with the metastatic potential of tumors, and inhibition of its expression significantly reduces the invasiveness of DLBCL cells (36, 37). Here, AKT1 is linked to cancer.